Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-002562
Filing Date
2025-04-25
Accepted
2025-04-25 16:05:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3224
  Complete submission text file 0001950047-25-002562.txt   4949
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Subject) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-06571 | Film No.: 25873918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 126 E. LINCOLN AVENUE PO BOX 2000 RAHWAY NJ 07065
Business Address
Smart Dalton E. III (Reporting) CIK: 0002003375 (see all company filings)

Type: 144